many separate groups. The questioner then emphasized the importance of including this perspective in other dialogues on this issue because once stakeholders start to gather resources and evaluate proposals, it will be more difficult to introduce a larger, broader agenda.
The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Pray, Leslie, Robinson, Sally "
6 Conducting Confirmatory Drug Safety and Efficacy Studies ."
Challenges for the FDA: The Future of Drug Safety, Workshop Summary . Washington, DC: The National Academies Press,
Please select a format: